“…Despite the many epidemiological studies that suggest a link between ARHL and the later development of AD (Uhlmann et al, 1989;Strouse and Hall, 1995;Quaranta et al, 2014;Bidelman et al, 2017;Haggstrom et al, 2018;Jayakody et al, 2018Jayakody et al, , 2020Panza et al, 2018;Ray et al, 2018;Brewster et al, 2020;Sardone et al, 2021), fewer cohort studies have found a statistically significant difference in pure tone hearing thresholds between AD and control subjects (Wang et al, 2005(Wang et al, , 2007Gimeno-Vilar and Cervera-Paz, 2010;Idrizbegovic et al, 2011;Lin et al, 2011Lin et al, , 2013Lodeiro-Fernandez et al, 2015;Villeneuve et al, 2017;Haggstrom et al, 2018;Hardy et al, 2019). Most of these studies had small sample sizes and were underpowered when detecting a difference in hearing thresholds (Wang et al, 2005(Wang et al, , 2007Gimeno-Vilar and Cervera-Paz, 2010;Idrizbegovic et al, 2011;Lin et al, 2011Lin et al, , 2013Lodeiro-Fernandez et al, 2015;Villeneuve et al, 2017;Haggstrom et al, 2018;Hardy et al, 2019).…”